Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
beta 2-Microglobulin Antibody (SPM617) - IHC-Prediluted, Novus Biologicals™
Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP248328
Description
beta 2-Microglobulin Monoclonal specifically detects beta 2-Microglobulin in Human, Primate samples. It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
beta 2-Microglobulin | |
Monoclonal | |
Unconjugated | |
10mM PBS and 0.05% BSA with 0.05% Sodium Azide | |
B2M | |
Full length recombinant human beta 2-Microglobulin protein (Uniprot: P61769) | |
Protein A or G purified | |
RUO | |
Primary | |
Beta2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy) | |
Store at 4C. | |
IgG1 κ |
Immunohistochemistry (Paraffin) | |
SPM617 | |
Immunohistochemistry-Paraffin | |
beta chain of MHC class I molecules, beta-2-microglobin, beta-2-microglobulin | |
Mouse | |
12 kDa | |
7 mL | |
Adaptive Immunity, Cancer, Cell Biology, Diabetes Research, Immunology | |
567 | |
Human, Primate | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Product Content Correction